Please refer to Section 7.4.5, ‘Thorough QT Study’ for a description of the dedicated
through QT study conducted in support of this application.
Study BCX1812-106 was a single-center, randomized, double-blind, double-dummy,
Phase 1 placebo- and active-controlled, 4-period, crossover thorough QT (TQT) study